Orion Porfolio Solutions, LLC
Position in APLS — Apellis Pharmaceuticals, Inc.
CIK 1360533
OMAHA, NE
Position in APLS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$0
+$0 QoQ
Shares Held
5,899
-81.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
8 quarters on record
Voting authority
Sole 6%
Shared 0%
None 94%
Common Shares in APLS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Orion Porfolio Solutions, LLC holds $65,856,861 across 60 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,853 | $5,887,740 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
23,454 | $5,651,710 | |
| 3 | RPRX |
Royalty Pharma plc
|
99,319 | $5,568,816 | |
| 4 | INSM |
INSMED Inc
|
35,467 | $3,781,491 | |
| 5 | ARGX |
Argenx SE
|
2,471 | $2,292,519 | |
| 6 | INVA |
Innoviva, Inc.
|
92,707 | $2,105,375 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
24,870 | $1,971,942 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,491 | $1,874,492 |
All Filings in APLS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 5,899 | Shares | Sole | 2026-05-13 | |
| 2024-09-30 | — | 31,418 | Shares | Sole | 2025-07-31 | |
| 2024-06-30 | — | 36,332 | Shares | Sole | 2025-07-31 | |
| 2024-03-31 | — | 27,079 | Shares | Sole | 2025-07-31 | |
| 2023-12-31 | — | 19,749 | Shares | Sole | 2025-07-31 | |
| 2023-09-30 | — | 27,396 | Shares | Sole | 2025-07-31 | |
| 2023-06-30 | — | 16,683 | Shares | Sole | 2025-07-31 | |
| 2023-03-31 | — | 17,325 | Shares | Sole | 2025-07-31 | |
| No filing history on record for this holder in this stock. | ||||||